Lv1
70 积分 2024-11-22 加入
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2026 American College of Cardiology Conference
1个月前
已完结
Reduced Variability to Aspirin Antiplatelet Effect by the Coadministration of Statins in High‐Risk Patients for Cardiovascular Disease
2个月前
已完结
Mechanisms, precision therapies, and technological frontiers in coronary atherosclerosis: a comprehensive review
4个月前
已完结
Role of proprotein convertase subtilisin/kexin type 9 inhibitors in patients with coronary artery disease undergoing percutaneous coronary intervention
6个月前
已完结
Diagnosing Resistance to a Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor
6个月前
已完结
Cost-Effectiveness Analysis of Evolocumab or Inclisiran in Combination with Statins Versus Statin Monotherapy Among Patients with ASCVD in China
8个月前
已完结
Gene expression of coregulators of proprotein convertase subtilisin/kexin type 9 in pateints with coronary artery disease
8个月前
已关闭
Expanding Our Understanding of Plaque Stabilization With PCSK9 Inhibitors
9个月前
已完结
Combinatorial, additive and dose-dependent drug–microbiome associations
9个月前
已完结
Cost-Effectiveness Analysis of Evolocumab or Inclisiran in Combination with Statins Versus Statin Monotherapy Among Patients with ASCVD in China
10个月前
已完结
皖公网安备34019202002308
